United States · 
Who invested in Nutcracker Therapeutics?
Nutcracker Therapeutics's investors include ARCH Venture Partners.
United States · Series C startup
Who invested in Nutcracker Therapeutics
Funding summaryUpdated 26 Oct 2026
$167Mraised across 1 round since 2022, from 1 source
- Latest round
- Series C, $167MMar 2022
- Investors
- 1
The rounds
- Mar 2022
Founders and team
From the SEC filings it signed: 5 on the team.
- Benjamin EldridgeExecutive Officeri
- Igor KhandrosExecutive Officer, Directori
- James ZhuExecutive Officeri
- Madhavan BalachandranExecutive Officeri
- Samuel DeutschExecutive Officeri
On the board, as filediRobert Nelsen
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nutcracker Therapeutics
How much has Nutcracker Therapeutics raised?
Nutcracker Therapeutics has raised $167M across 1 round since 2022.
When did Nutcracker Therapeutics last raise?
Nutcracker Therapeutics's most recent round was a Series C of $167M in Mar 2022.
What was Nutcracker Therapeutics's biggest round?
Its most recent round, $167M in Mar 2022, is also its largest on record.
Who backed Nutcracker Therapeutics first?
Nutcracker Therapeutics's first round on record, in Mar 2022, was backed by ARCH Venture Partners.
What stage is Nutcracker Therapeutics at?
Nutcracker Therapeutics's latest named round is a Series C, in Mar 2022.
Where is Nutcracker Therapeutics based?
Nutcracker Therapeutics is based in the United States.
Companies like Nutcracker Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.